CN100367951C — 丁苯酞静脉乳剂及其应用
Assigned to SHIJIAZHUAN PHARMA GROUP NBP PHARMACEUTICAL Co Ltd · Expires 2008-02-13 · 18y expired
What this patent protects
本发明涉及的是丁苯酞静脉乳剂及其应用。本发明丁苯酞静脉乳剂供静脉注射或输注,其粒径范围在10-2000nm。丁苯酞静脉乳剂的组成为:丁苯酞;油;乳化剂;等渗剂;注射用水。用二步乳匀分散法进行乳化制得。丁苯酞静脉乳剂的优势在于:掩盖丁苯酞的特殊香味;增加丁苯酞的溶解度和稳定性,从而提高生物利用度;静脉注射乳剂后,可增加丁苯酞脑组织的靶向性,降低其毒副作用等。
USPTO Abstract
本发明涉及的是丁苯酞静脉乳剂及其应用。本发明丁苯酞静脉乳剂供静脉注射或输注,其粒径范围在10-2000nm。丁苯酞静脉乳剂的组成为:丁苯酞;油;乳化剂;等渗剂;注射用水。用二步乳匀分散法进行乳化制得。丁苯酞静脉乳剂的优势在于:掩盖丁苯酞的特殊香味;增加丁苯酞的溶解度和稳定性,从而提高生物利用度;静脉注射乳剂后,可增加丁苯酞脑组织的靶向性,降低其毒副作用等。
Drugs covered by this patent
- Aveed (TESTOSTERONE UNDECANOATE) · Marius
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.